Telesis Bio Inc.
TBIODelisted Sep 20, 2024- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001850079
Telesis Bio Inc. was delisted on Sep 20, 2024; its insiders filed their last Form 4 on Jul 26, 2024; 21 institutions reported holding it in 13F filings for Q1 2024, worth $4.77M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Telesis Bio Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Telesis Bio Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Golub Steven J | Director | 8,390 | Jul 26, 2024 | 0 |
| Hlavinka Sarah E. | Director | 8,390 | Jul 26, 2024 | 0 |
| Weissman James B | Director | 8,390 | Jul 26, 2024 | 0 |
| Krueger Todd | Director | 8,390 | Jul 26, 2024 | 0 |
| Hodges Michael R. | Director | 8,390 | Jul 26, 2024 | 0 |
| Nachtsheim Jami K | Director | 101,679 | May 3, 2024 | 0 |
| Tsingos Christine A | Director | 104,491 | May 3, 2024 | 0 |
| Herrema Gregory J. | Director | 184,677 | May 3, 2024 | 0 |
| Witney Frank | Director | 115,736 | May 3, 2024 | 0 |
| Tumolo Annette | Director | 157,769 | May 3, 2024 | 0 |
| Esser Eric Eugene | President & CEO | 129,260 | Apr 19, 2024 | 0 |
| Cutler Rob | Chief Legal Officer | 35,718 | Mar 5, 2024 | 0 |
| Gibson Daniel Glenn | Chief Technology Officer | 105,562 | Mar 5, 2024 | 0 |
| Nelson Todd Robert | Chief Executive Officer | 174,240 | Mar 5, 2024 | 0 |
| Kullback William J | Chief Financial Officer | – | Dec 5, 2023 | 0 |
| Meister Paul M | Director, 10% Owner | 108,270 | Jun 8, 2023 | 0 |
| Northpond Ventures GP, LLC | Director, 10% Owner | – | Jun 7, 2023 | 0 |
| Northpond Ventures, LP | Director, 10% Owner | – | Jun 7, 2023 | 0 |
| Rubin Michael P. | Director, 10% Owner | – | Jun 7, 2023 | 0 |
| BroadOak Fund IV, LLC | 10% Owner | – | Jun 7, 2023 | 0 |
| Snider William | Director, 10% Owner | 20,630 | Jun 7, 2023 | 0 |
| Hunter Brent M. | Vice President, Finance & PFO | – | Aug 8, 2022 | 0 |
| Jackson Andrea Liapis | Director | – | Jun 15, 2022 | 0 |
| McNealey Jennifer Isacoff | Chief Financial Officer | – | Mar 1, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 8, 2023 (view filing) | May 4 | 4 days | Nelson Todd RobertPresident & CEO | SSale | −2.58K | $2.83 | −$7.29K | −1.9%136.1K after | |
| May 8, 2023 (view filing) | May 4 | 4 days | Gibson Daniel GlennChief Technology Officer | SSale | −1.19K | $2.83 | −$3.37K | −1.2%102.1K after | |
| May 8, 2023 (view filing) | May 4 | 4 days | Cutler RobChief Legal Officer | SSale | −1.17K | $2.83 | −$3.32K | −4.4%25.5K after | |
| Nov 14, 2022 (view filing) | Nov 11 | 3 days | Nelson Todd RobertPresident & CEO | PPurchase | +122.5K | $1.56 | +$191.1K | New position122.5K after |